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Abstract
Few studies have been conducted that have examined the long-term effect of different doses of 
physical activity (PA) on weight change in overweight adults without a prescribed reduction in 
energy intake. This study examined the effect of different prescribed doses of PA on weight 
change, body composition, fitness and PA in overweight adults. 278 overweight adults (BMI: 25.0 
to 29.9 kg/m2; Age: 18 to 55 years) with no contraindications to PA were randomized to one of 
three intervention groups for a period of 18 months. MOD-PA was prescribed 150 min/wk and 
HIGH-PA 300 min/wk of PA. SELF was provided a self-help intervention to increase PA. There 
was no recommendation to reduce energy intake. MOD-PA and HIGH-PA was delivered in a 
combination of in-person and telephone contacts across 18 months. 18-month percent weight 
change was −0.7±4.6% in SELF, −0.9±4.7% in MOD-PA, and −1.2±5.6% in HIGH-PA. Subjects 
were retrospectively grouped as remaining within ±3% of baseline weight (WT-STABLE), losing 
>3% of baseline weight (WT-LOSS), or gaining >3% of baseline weight (WT-GAIN) for 
secondary analyses. 18-month weight change was 0.0±1.3% for WT-STABLE, +5.4±2.6% for 
WT-GAIN, and −7.4±3.6% for WT-LOSS. 18-month change in PA was 78.2±162.6 min/wk for 
WT-STABLE, 74.7±274.3 for WT-GAIN, and 161.9±252.6 min/wk for WT-LOSS. The weight 
change observed in WT-LOSS was a result of higher PA combined with improved scores on the 
Eating Behavior Inventory, reflecting the adoption of eating behaviors to facilitate weight loss. 
Strategies to facilitate the maintenance of these behaviors are needed to optimize weight control.
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INTRODUCTION
Estimates indicate that 65% to 70% of adults are overweight, with over 30% of adults 
classified as obese (1). Excess body weight has been shown to increase the risk of various 
health outcomes (2). While it is important to reduce body weight, there is also a need to 
implement interventions to curtail weight gain and the development of obesity, as well as 
elicit even modest reductions in body weight.
Physical activity (PA) when coupled with a reduction in energy intake enhances initial and 
long-term weight loss (3). PA may play a role in the primary prevention of weight gain, and 
the US Dietary Guidelines for Americans (4) recommends 60 minutes of moderate-intensity 
PA for the prevention of weight gain. More recent literature reviews conclude that PA 
ranging from approximately 150–250 min/wk results in weight loss of <3 percent of initial 
body weight (3, 5). As acknowledged in these reviews, few studies have used randomized 
designs with interventions implemented over an extended period (i.e., >12 months). 
Moreover, relatively recent claims in the popular media have suggested to the general public 
that physical activity has limited effects on body weight regulation, and has inferred that 
physical activity may actually contribute to weight gain and the increasing rates of obesity 
(6). Thus, it is important for research to quantify the effect of various doses of physical 
activity on change in body weight within the context of prospective intervention studies, as 
this information will inform clinical recommendations and clarify public health information 
regarding this matter.
The purpose of this study was to examine the effect of different prescribed doses of 
moderate-to-vigorous intensity PA on body weight in overweight adults (BMI = 25.0 to 
<30.0 kg/m2). Secondary outcomes included body composition, fitness, and PA. In addition, 
secondary analyses were performed with subjects classified as having remained within ±3% 
of baseline weight (WT-STABLE), lost weight of >3% compared to baseline weight (WT-
LOSS), or gained weight of >3% compared to baseline weight (WT-GAIN). The criterion of 
±3% of baseline weight being used to define weight stability is based on the published 
criteria proposed by Stevens et al. (7). Secondary analysis from prior studies conducted by 
our research group have provided additional insight into the effect of PA on weight change 
and the dose of PA that may be necessary to elicit significant long-term changes in weight 
(8, 9), and therefore we have taken a similar approach in this study.
METHODS
Subjects
Two-hundred seventy eight adults were recruited between 2003 and 2006 to participate in 
this study using newspaper, television, radio, and direct mail advertisements. Subjects were 
18 to 55 years of age, had a BMI of 25.0 to 29.9 kg/m2, and reported being sedentary, which 
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was defined as <3 days per week of <20 minutes per day of structured exercise. Exclusion 
criteria included a medical condition that prohibited participation in prescribed levels of PA, 
a history of coronary heart disease, a medical condition that may affect body weight, taking 
medication that would affect body weight (i.e., synthroid) or blood pressure (i.e., beta 
blocker), or recent weight loss of ≥10 pounds over the prior 12 months.
A medical history and PA readiness questionnaire (10) were completed prior to entry into 
this study and were used to determine eligibility. The participant’s physician provided 
written documentation that the proposed intervention was not contraindicated. Written 
informed consent was provided by participants prior to initiating this study, and the protocol 
was approved by the Institutional Review Board of the University of Pittsburgh (Pittsburgh, 
PA). Eligible subjects participated in baseline assessments as describe below prior to 
randomization to determine final eligibility.
Outcome Assessments
Subjects completed assessments of the primary outcomes at 0, 6, 12, and 18 months as 
described below. Subjects received $50 at 6, 12, and 18 months for completion of these 
assessments.
Body weight was assessed using a calibrated balance-beam scale to the nearest 0.1 kg (0.25 
pounds) with the subject clothed in a cloth hospital gown. Height was assessed using a wall-
mounted stadiometer to the nearest 0.1 cm. BMI was computed as kg/m2.
Body composition was assessed using bioelectrical impedance. The equation proposed by 
Segal et al. (11) was used to compute lean body mass (LBM), with percent body fat 
computed as: Percent Body Fat = [(weight – LBM)/weight]*100. Fat distribution was 
determined using anthropometry and included waist circumference measured horizontally at 
the level of the umbilicus, hip circumference measured at the widest observed aspect of the 
buttocks, and sagittal diameter measured at the iliac crests. Measurements were represented 
as the average of two measures that differed by ≤1.0 cm.
Fitness was assessed using a submaximal graded exercise on a treadmill as previously 
described (9). PA was assessed using a modified version of the questionnaire developed for 
the Harvard Alumni Study (12), with activity assessed for the prior 7-day period. Subjects 
reported periods of walking performed for exercise or purposeful activity, with household 
and occupational walking excluded. Additionally, subjects reported other fitness, sport, or 
recreational periods of PA. Energy expenditure (kcal/wk) and minutes of PA were computed 
as previously described (9). Briefly, energy expenditure was computed using previously 
published scoring algorithms (12) and classifications based on the compendium of physical 
activity (13). Minutes of activity was summed as the reported minutes of moderate-to-
vigorous physical activity reported on the questionnaire.
Dietary intake was assessed using a food frequency questionnaire (14, 15). To determine if 
subjects were engaging in eating behaviors (i.e., weighing food, self-monitoring, self-
weighing, etc.) consistent with weight control, the Eating Behavior Inventory (EBI) (16) was 
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completed at each assessment period. A higher score is indicative of engagement in more 
eating behaviors recommended for weight control.
Intervention
Subjects were randomized to either a moderate PA dose intervention, high PA dose 
intervention, or a self-help intervention for a period of 18 months. The interventions were 
delivered in a closed-group format to minimize contamination between the intervention 
groups. Randomization was performed by the study statistician using a computer program 
with randomization blocked by gender.
Moderate PA dose intervention (MOD-PA)—MOD-PA participated in a behavioral 
intervention to promote progression and maintenance of 150 min/wk of structured PA by 
week 12, with the goal to sustain this dose of activity for the remainder of the 18 month 
intervention. Subjects were encouraged to spread the PA over a period of at least 5 days per 
week and to engage in bouts of PA that were at least 10 minutes in duration. Intensity was 
prescribed as moderate-to-vigorous, which was defined as 55–85% of age-predicted 
maximal heart rate or 11–15 on the 15-point rating of perceived exertion scale. For months 
1–6, subjects attended weekly behavioral intervention sessions to promote the adoption of 
this dose of PA, with each month consisting of 3 weekly group sessions and 1 individual 
session with their assigned PA counselor. During months 7–18 subjects attended 2 group 
intervention sessions per month combined with 2 telephone calls per month with their 
assigned counselor so that weekly contact was sustained throughout the 18 month 
intervention session. The counselor followed a structured script for the telephone 
intervention calls, with the goal to complete this call in ≤10 minutes.
Each intervention session was supplemented with a written lesson that highlighted the key 
points of the behavioral session. During each session subjects were encouraged to exercise 
on-site with the intervention staff, with an additional supervised session offered on the 
weekends during months 1–3 to facilitate the initial adoption of the prescribed dose of PA. 
All remaining PA was performed under non-supervised conditions.
Subjects were provided guidance on healthy eating behaviors consistent with a balanced 
nutritional diet, but an energy restricted diet was not provided nor encouraged. Subjects 
received a monthly newsletter that included general health information along with pertinent 
information related to the logistics of the study.
High PA dose intervention (HIGH-PA)—HIGH-PA received an 18 month intervention 
that was virtually identical to the intervention described for MOD-PA. However, HIGH-PA 
was prescribed PA that progressed from 100 to 300 min/wk, with the dose of PA increasing 
by 25 min/wk at 4-week intervals.
Self-help group (SELF)—SELF only attended assessment visits at 0, 6, 12, and 18 
months, with no additional intervention contact provided by the staff. Subjects received a 
PA self-help manual (Active Living Everyday) (17), along with the same monthly newsletter 
provided to the MOD-PA and HIGH-PA groups. This SELF intervention is modeled after 
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prior intervention (18), and was also intended to maintain contact to enhance retention of 
subjects in this group across the 18 month study period.
Statistical Analysis
An a-priori power calculation was computed based on expected differences in body weight 
at 18 months between the randomized groups. Randomization of 78 subjects per group 
would provide 80% power at an alpha level of 0.05 to detect a moderate effect size of 0.45 
for differences in weight loss between the groups. The intention-to-treat analyses for this 
study are based on samples of 84 subjects for SELF, 76 subjects for MOD-PA, and 88 
subjects for HIGH-PA.
Statistical analyses were performed using SAS (version 9.2), with the type I error rate fixed 
at 0.05 (two-tailed). Normality of the outcome variables was checked using the 
Kolmogorov-Smirnov test. For dietary intake (kcal/d), PA (min/wk), and PA (kcal/wk), log-
transformation was made as the results of the tests. Separate mixed effects models using the 
unstructured dependence structure were fit to the outcomes measured at baseline, 6, 12, and 
18 months. Alternative mixed effects models with the three change scores: baseline to 
month 6, baseline to month 12, baseline to month 18 as the outcomes were fit with the 
baseline value of the outcome of interest being adjusted in the models as covariate.
Secondary analyses were performed with subjects classified as having remained within ±3% 
of baseline weight (WT-STABLE), lost weight of >3% compared to baseline weight (WT-
LOSS), or gained weight of >3% compared to baseline weight (WT-GAIN). The criterion of 
±3% of baseline weight being used to define weight stability is based on the published 
criteria proposed by Stevens et al. (7). All analyses were intention-to-treat analyses with 
baseline data carried forward for missing data at subsequent assessment periods.
RESULTS
As shown in Figure 1, 278 individuals attended an orientation session, consented to 
participate in this study, and completed baseline assessments. This resulted in 269 subjects 
eligible to be randomized to the intervention phase of this study with 89, 82, and 98 subjects 
randomized to SELF, MOD-PA, and HIGH-PA, respectively. Prior to the completion of this 
study, 21 subjects were removed for reasons shown in Figure 1, which resulted in 248 
subjects eligible to complete the study and 196 subjects (79% of eligible subjects) providing 
data at the 18 month assessment. Thus, the intention-to -treat analyses are based on the 248 
subjects eligible to complete this study. The justification for not including the 21 subjects 
who did not receive their randomization assignment, became pregnant, had a non-study 
related medical condition, or relocated to a geographical region that did not allow them to 
attend the intervention or assessments visits is similar to the approach that we have used in 
previously published studies (8, 9, 19). Moreover, these factors were a prior exclusionary 
criteria. There was no significant difference in attrition rates between groups based on chi-
square analysis. There were no significant unexpected serious adverse events reported. 
Demographic characteristics are shown in Table 1.
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PA across 0, 6, 12 and 18 months revealed a significant Group X Time interaction effect 
(p<0.001). Post-hoc analyses with Bonferroni adjustment showed that the Group X Time 
interaction effect remained statistically significant for comparisons between HIGH-PA and 
both MOD-PA and SELF; however, the comparison of MOD-PA and SELF was not 
statistically significant. Increase in PA from baseline to 6, 12, and 18 months was 
244.6±233.3, 188.7±216.3, and 154.8±237.5 min/wk in HIGH-PA compared to 
131.4±150.6, 98.4±148.6, 66.1±169.5 min/wk in MOD-PA and 95.4±224.8, 71.0±236.4, 
74.6±223.9 min/wk in SELF (Table 2).
Energy Intake
Changes from baseline to 18 months were −201.0±517.3 kcal/d for dietary intake, 
−0.7±6.7% for percent fat intake, +0.6±7.0% for percent carbohydrate intake, and 
+0.2±2.6% for percent protein intake. There was no group by time interaction for changes in 
these dietary intake parameters. Likewise there was a significant increase in the EBI score 
from 73.1±9.9 to 78.3±10.8 (p<0.001), suggesting an improvement in eating and weight loss 
behaviors, with no significant difference between groups.
Body Weight
Modest weight loss occurred in all treatment groups at 6, 12, and 18 months with no 
significant difference between groups (Table 3). Percent weight change at 6 months was 
−1.3±3.6%, −1.8±3.5%, and −1.9±3.8% in SELF, MOD-PA, and HIGH-PA, respectively. 
Percent weight change from 0 to 18 months was −0.7±4.6% in SELF, −0.9±4.7% in MOD-
PA, and −1.2±5.6% in HIGH-PA with no significant difference between groups. Waist 
circumference decreased from 90.4±8.4 cm to 89.4±9.4 cm (p<0.0001) and percent body fat 
from 33.4±4.2% to 32.9±5.2% (p<0.0001), with no significant difference between groups 
(Table 2).
Fitness
There was a significant Group X Time (p<0.001) interaction for change in fitness between 
the groups. The increase in time to achieve 85% of age-predicted maximal heart rate from 
baseline to 6 months was 1.6, 3.3, and 3.4 minutes for SELF, MOD-PA, and HIGH-PA, 
respectively (Table 2). At 18 months the change from baseline was 1.6 minutes for SELF, 
2.0 minutes for MOD-PA, and 2.8 minutes for HIGH-PA.
Analysis by Weight Change Categories
Subjects were classified as having remained within ±3% of baseline weight (WT-STABLE), 
lost weight of >3% compared to baseline weight (WT-LOSS), or gained weight of >3% 
compared to baseline weight (WT-GAIN). The criterion of ±3% of baseline weight being 
used to define weight stability is based on the published criteria proposed by Stevens et al. 
(7). Overall, 53.2% (N=132) of subjects remained weight stable, 27.4% (N=68) lost weight, 
and 19.4% (N=48) gained weight using these criteria at 18 months. Chi-square analysis 
showed no significant difference between randomized groups for the number of subjects in 
these weight categories (chi-square p-value = 0.80).
Jakicic et al. Page 6













Weight change at 18 months was +5.4±2.6% (4.0±1.8 kg) for WT-GAIN, 0.0±1.3% 
(0.0±1.0 kg) for WT-STABLE, and −7.4±3.6% (−5.4±2.6 kg) for WT-LOSS (p<0.001) 
(Table 3 and Figure 2). Changes in waist circumference and percent body fat followed the 
same pattern as change in body weight. ANOVA was also performed with subjects 
retrospectively grouped according to level of physical activity at 6, 12, and 18 months. 
These retrospective groupings were defined as <150 min/wk, 150 to <225 min/wk, 225 to 
<300 min/wk, and ≥300 min/wk. Results are presented in Figure 4 and showed significant 
improvement in weight loss with a higher dose of PA at 6 (p=0.012) and 12 months 
(p=0.001), with weight loss not differing by PA category at 18 months (p=0.273).
There was a significant Group X Time interaction for change in PA between WT-STABLE, 
WT-LOSS, and WT-GAIN (p<0.001). The increase in PA from baseline to 18 months was 
78.2±162.6 min/wk for WT-STABLE, 161.9±252.6 min/wk for WT-LOSS, and 74.7±274.3 
min/wk for WT-GAIN (Figure 3 and Table 3). There was a significant Group X Time 
(p<0.001) interaction for change in fitness between the groups with the increases in time to 
achieve 85% of age-predicted maximal heart rate being 4.7, 1.2, and 1.4 minutes for WT-
LOSS, WT-STABLE, and WT-GAIN, respectively (Table 3).
There was a modest but significant overall decrease in dietary intake (1822.5±860.6 to 
1621.5±782.6 kcal/d) and percent dietary fat intake (39.2±7.9% to 38.4±7.8%), an increase 
in percent carbohydrate intake (46.0±8.7% to 47.0±8.6%), with no change in percent protein 
intake (15.3±2.9% to 15.5±2.9%) from baseline to 18 months, with no significant difference 
between WT-STABLE, WT-LOSS, and WT-GAIN. However, there was a significant Group 
X Time interaction (p<0.001) for change in EBI score, with change from baseline to 18 
month scores being 2.8±6.8, 10.0±9.9, and 4.9±10.4 for WT-STABLE, WT-LOSS, and WT-
GAIN, respectively.
DISCUSSION
Two recent comprehensive reviews of the literature have reported that PA interventions 
result in a modest decrease in body weight. The literature review conducted for the Physical 
Activity Guidelines for Americans (5, 20) concluded that weight loss is typically 1–3% of 
initial body weight in response to ≥180 min/wk of PA, with PA <150 min/wk resulting in no 
reduction in body weight. The American College of Sports Medicine concluded that 150–
250 min/wk of PA results in a similar magnitude of weight loss (3). Few of these studies 
conducted between 1998 and 2008 were long-term in duration, whereas the current study 
reports on the effects of an 18-month intervention. The results of the current study that 
included only overweight adults are consistent with these prior reviews of the literature that 
included studies of both overweight and obese adults. The current study demonstrated that a 
prescribed dose of 150 min/wk or 300 min/wk of PA resulted in <2% weight loss in 
overweight adults. These results are also consistent with earlier reviews of the literature 
conducted in the late 1990’s (2, 21). However, subjects in this study were not prescribed a 
reduction in energy intake, which most likely reduced the potential of a greater reduction in 
body weight in MOD-PA and HIGH-PA. We previous demonstrated that a prescribed 
reduction in energy intake combined with a sufficient dose of PA results in approximately 
an 8–10% reduction in body weight by the end of a 6 month intervention (8, 9, 19). 
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Moreover, the progression of PA followed a reasonable clinical approach to minimize injury 
risk from overuse too early within the intervention, and is similar to a progression that we 
have used in a prior weight loss study (8, 9). However, this resulted in the MOD-PA group 
reaching their prescribed maximal PA dose much more rapidly than the HIGH-PA group, 
which may have influenced the weight loss observed when comparing these intervention 
conditions. However, despite this difference in progression to maximal PA dose, the HIGH-
PA group was still prescribed a higher dose of PA during the final 15 months of the 
intervention compare to both MOD-PA and SELF, yet this still did not result in significant 
differences in weight loss.
Despite the findings from the primary analysis of the data that demonstrated a modest effect 
of PA on change in body weight in overweight adults, results from secondary analysis may 
provide an enhanced understanding of these data. When grouped based on whether there 
was weight gain (WT-GAIN), weight loss (WT-LOSS), or weight stability (WT-STABLE) 
it does appear that an increase in PA can result in significant weight loss. Overweight 
participants classified as WT-LOSS showed a weight loss of 7.4% (5.4 kg) by the 
completion of the 18 month intervention, and this was accompanied by an increase in PA by 
228 min/wk at 6 months, and despite decreasing at 18 months still remained 161 min/wk 
above baseline. This may suggest that when compliant to an increase in the dose of PA that 
is 161 to 228 min/wk above baseline, weight loss may be significant in overweight adults. 
Of interest is that this dose of PA is similar to recent PA guidelines (5, 20) and 
recommended by the American College of Sports Medicine (3). However, it needs to be 
emphasized that these findings are based on secondary analysis with subjects retrospectively 
grouped by weight change to examine the dose of PA that may contribute to differences in 
these observed changes in weight.
Despite these findings, concluding that PA alone can result in the magnitude of weight loss 
observed in WT-LOSS within the retrospective secondary analysis may be misleading. 
There is some indication that participants classified as WT-LOSS, who lost 7.4% of their 
body weight compared to baseline (Table 4 and Figure 2) also made significant changes in 
their eating behavior as measured by the EBI questionnaire (Table 4), despite the lack of an 
intervention promoting a reduction in energy intake. In fact, these results are consistent with 
other studies with interventions that have prescribed both reductions in energy intake and 
increases in PA for weight loss (3, 22). Thus, it appears that changes in both behaviors are 
important to maximize weight loss in overweight adults. Moreover, as previously reported, 
weight loss behaviors such as PA and diet appear to cluster, and the results from this study 
support this initial observation (23). This may suggest that for some individuals an increase 
in PA may also indirectly affect eating behavior and potentially dietary intake that can result 
in weight loss, but this requires further study as few studies have been able to confirm this 
effect.
This study demonstrates that approximately 20% of overweight subjects gained significant 
weight, and this weight gain can be on the magnitude of approximately 4 kg over a period of 
18 months (Figure 2 and Table 4). Weight gain was also accompanied by an increase in 
abdominal adiposity, which has been shown to increase risk of chronic health conditions 
such as cardiovascular disease and diabetes (24). Identifying characteristics of those 
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individuals who gained weight may be important to identify for whom a behavioral 
intervention that focuses primarily on increasing PA is not effective for preventing weight 
gain.
The results of this study demonstrate the challenges of traditional behavioral intervention 
programs to maintain a sufficient dose of PA to reduce body weight. During the initial 6 
months the MOD-PA group increased PA above baseline values by 131 min/wk and the 
HIGH-PA group increased PA by 245 min/d, which was 87.3% and 81.7% of the 150 
min/wk and 300 min/wk goals for these groups, respectively. At 18-months the PA was 66 
min/wk and 155 min/wk above baseline levels in MOD-PA and HIGH-PA, respectively, 
reflecting a 49.6% and 36.7% decrease compared to the peak increases observed at 6 
months. This study did implement an intervention that included intensive contact and 
included theoretically based behavioral constructs to promote adherence. This suggests the 
need for additional research to implement effective interventions to achieve and maintain 
targeted PA goals in overweight adults. This was identified as a key research area by the 
Advisory Committee for the Physical Activity Guidelines for Americans (20).
The SELF group also showed increases in PA of 74.6 min/wk (442 kcal/wk) from baseline 
to 18 months (see Table 2). While this increase was only 49.7% of the consensus public 
health recommendation to increase PA by 150 min/wk, this increase was comparable to 
what was observed in MOD-PA. SELF was provided with a self-help manual that is 
evidence-based to improve physical activity, which may have contributed to the increase in 
PA observed in response to this intervention. However, in prior studies in which we have 
used a self-help manual, this type of intervention has demonstrated a minimal effect on 
behavior change resulting in PA increasing by 89 kcal/wk at 6 months and 122 kcal/wk at 24 
months (18). Thus, future studies should examine the feasibility and effectiveness of these 
self-help interventions for improving physical activity that may affect body weight and 
related chronic disease risk factors.
This study is not without limitations. Dietary intake was assessed using a food frequency 
questionnaire, and this may explain why those individuals who gained weight (WT-GAIN) 
reported a decrease in total energy intake over the 18-month intervention (Table 4) based on 
retrospective secondary analysis. There was little change in percent dietary fat intake and the 
adoption of weight loss eating behaviors (EBI) for those who gained weight, whereas those 
who lost weight (WT-LOSS) showed decreases in dietary fat and increases in weight loss 
eating behaviors. This may demonstrate the difficulty of accurately assessing energy intake 
in a relatively large randomized intervention study, and future studies may need to use 
alternative assessment methods to more accurately assess changes in dietary intake in 
response to a behavioral intervention. This study also used a questionnaire to assess PA, 
with WT-LOSS reporting significantly greater increases in PA compared to WT-GAIN and 
WT-STABLE. However, the results of this study also demonstrated that WT-LOSS had 
significantly greater increases in objectively measured fitness (Table 4), which supports the 
finding that PA improved more in this group compared to the others. The pattern of change 
in PA also mirrored the pattern of change in fitness between SELF, MOD-PA, and HIGH-
PA. However, PA was based on self-report and future studies should consider assessing PA 
using objective methods (e.g, accelerometers, multi-sensor devices) to define the dose of PA 
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necessary for weight loss or weight maintenance in overweight adults. Moreover, this study 
used self-reported dietary intake, which has been shown to under-report dietart intake to 
objective methods such as doubly-labeled water, which may influence the interpretation of 
our results concerning the contribution to energy intake on observed changes in body 
weight. The body composition data are also based on bioelectrical impedance analysis and 
anthropometry, and future studies should consider the use of dual-energy x-ray 
absorptiometry (DXA), magnetic resonance imaging (MRI), and computed tomography 
(CT) to provide additional objective data with regard to the effects of this type of PA 
intervention on changes in body composition and fat distribution.
It is important to highlight that this study was performed in an outpatient setting, and this 
may explain the difference in findings related to weight change in this study compare to 
other studies that have used supervised PA. For example, 16-month results reported by 
Donnelly et al. (25) showed a 4.8 kg difference in weight between PA and control groups for 
men and a 5.2 kg in weight between the groups for women, with PA involving increasing 
energy expenditure by 371 kcal/d in men and 209 kcal/d in women. However, these doses of 
PA resulted in weight loss in men but prevention of weight gain in women compared to the 
control groups. Ross et al. (26) reported a 6.5 kg reduction in weight in response to an 
exercise dose of 3500 kcal/wk with no change in energy intake over a period of 14. Thus, 
the lower change in weight observed in this current study may reflect lower adherence to the 
prescribed dose of PA that may not be able to be detected using the self-report measures 
used in this study. However, Slentz et al. (27) showed that PA equivalent to 20 miles per 
week of walking or jogging, which would approximate 300 to 400 minutes per week 
assuming a 15 to 20 minute per mile walking pace, resulted in 2.9±2.8 kg of weight loss 
over a period of 8 months. Church et al. (28) reported on weight loss resulting from different 
doses of supervised PA with no change in dietary intake. A higher dose of PA (12 kcal/kg/
week) resulted in 1.5 kg of weight loss, which was not greater than the 2.1 kg or 1.4 kg 
weight loss resulting from 8 kcal/kg/wk or 4 kcal/kg/wk, respectively. This may suggest that 
higher doses of PA may result in compensation of energy intake that affects energy balance, 
and this requires further investigation.
In summary, the mean change in body weight resulting from an intervention that promotes 
150 to 300 min/wk of moderate-intensity PA with no reduction in energy intake is <2.0 kg. 
However, approximately 25% of subjects lost >3% of their initial body weight in this study, 
with these subjects categorized retrospectively as WT-LOSS for secondary analysis. 
Individuals categorized as WT-LOSS for these secondary analyses do appear to be more 
compliant with initially increasing PA by 245 min/wk and maintaining an increase of at least 
161 min/wk at the conclusion of this 18-month study. These individuals may also self-select 
to change their eating behaviors, which in combination with PA, resulted in the significant 
decrease in weight. Health-care providers should promote modifications in these behaviors; 
however, strategies continue to be needed to facilitate the adoption and maintenance of these 
behaviors long-term.
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Flow chart of participant recruitment and retention.
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Percent weight change by 18 month weight change classification.
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Change in physical activity by 18 month weight change classification.
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Change in body weight by level of self-reported physical activity at 6, 12, and 18 months.
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Table 1
Summary of Demographic Characteristics of Subjects.








Randomly Assigned 89 82 98 269
Intention-to-Treat Analysis 84 76 88 248
Completers Analysis 69 55 72 196
Gender (Females)
Randomly Assigned 82 (92.1%) 74 (90.2%) 90 (91.8%) 246 (91.4%)
Intention-to-Treat Analysis 77 (91.7%) 69 (90.8%) 81 (92.0%) 227 (91.5%)
Completers Analysis 62 (89.9%) 50 (90.9%) 66 (91.7%) 178 (90.8%)
Age (years)
Randomly Assigned 44.7±7.9 43.5±8.8 45.0±8.4 44.4±8.4
Intention-to-Treat Analysis 44.8±7.8 44.4±8.2 45.6±7.9 44.9±7.9
Completers Analysis 45.4±7.3 44.6±8.3 46.0±8.1 45.4±7.9
Weight (kg)
Randomly Assigned 73.9±7.9 74.1±8.3 74.5±8.3 74.2±8.2
Intention-to-Treat Analysis 73.7±8.0 74.2±8.4 74.3±8.2 74.1±8.2
Completing Treatment 73.8±8.3 74.6±8.2 73.6±7.6 74.0±8.0
Body Mass Index (kg/m2)
Randomly Assigned 27.1±1.7 27.1±1.7 27.0±1.6 27.1±1.7
Intention-to-Treat Analysis 27.1±1.7 27.2±1.8 27.0±1.6 27.1±1.7
Completing Treatment 27.0±1.7 27.2±1.8 26.9±1.6 27.0±1.7
Ethnicity*
American Indian or Alaska Native N=0, 0% (N=0, 0%) N=0, 0% (N=0, 0%) N=1, 1.1% (N=0, 
0%)
N=1, 0.4% (N=0, 
0%)
Asian N=1, 1.2% (N=1, 1.5%) N=2, 2.6% (N=2, 
3.6%)
N=0, 0% (N=0, 0%) N=3, 1.2% (N=3, 
1.5%)




N=37, 14.9% (N=31, 
15.8%)
Hispanic, Latino, Portuguese, Cape 
Verdean
N=2, 2.4% (N=2, 2.9%) N=1, 1.3% (N=1, 
1.8%)
N=1, 1.1% (N=1, 
1.4%)
N=4, 1.6% (N=4, 
2.0%)
Native Hawaiian or Other Pacific 
Islander
N=0, 0% (N=0, 0%) N=0, 0% (N=0, 0%) N=0, 0% (N=0, 0%) N=0, 0% (N=0, 0%)






Other N=2, 2.4% (N=0, 0%) N=1, 1.3 (N=1, 
1.8%)
N=1, 1.1% (N=1, 
1.4%)
N=4, 1.6% (N=2, 
1.0%)
Not Specific – Missing N=0, 0% (N=0, 0%) N=1, 1.3% (N=1, 
1.8%)
N=0, 0% (N=0, 0%) N=1, 0.4% (N=1, 
0%)
*
indicates that numbers not in parentheses are based on the intent-to-treat analysis (N=248) and numbers in parentheses are based on subjects 
completing 18 months (N = 196).
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